Zufinib 250 mg Tablet

Introduction of Zufinib 250 mg Tablet

Zufinib 250 mg Tablet is an anti-cancer drug used for treating non-small cell lung cancer (NSCLC) that has spread to other parts of the body, in patients with abnormal EGFR genes who haven't received prior cancer treatment. This Zufinib 250 Tablet is not suitable for children or adolescents as its safety and effectiveness in these groups are unknown.

Zufinib 250 Tablet may cause side effects, including diarrhoea, skin rash, and nausea. It may also cause serious side effects, such as liver damage and lung inflammation. It is important to talk to your doctor about any side effects you experience while taking Zufinib 250 mg.

Do not use if you have an allergy to Zufinib Tablet or any of its ingredients. Before using this Zufinib 250 Tablet, consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Before taking Zufinib 250 Tablet talk to your doctor about the potential risks and benefits of taking this medication, as well as any other questions or concerns you may have and also important to let your doctor you have any pre-existing diseases or using any medications, vitamins supplements, herbal medicine you are taking.

Uses of Zufinib 250 mg Tablet

​Non-small cell lung cancer: Zufinib 250 mg Tablet is used to treat non-small cell lung cancer, which is a type of lung cancer that affects a large number of cells in the lung. ​

Benefits of Zufinib 250 mg Tablet

Zufinib 250 Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Zufinib can help to slow the progression of cancer.

Zufinib Tablet may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life.

Zufinib 250 mg Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.

Side Effects of Zufinib 250 mg Tablet

​​Like all medications, Zufinib 250 mg Tablet can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.​

Most Common Side Effects of Zufinib 250 mg Tablet

• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair

Common Side Effects of Zufinib 250 mg Tablet

• Liver Damage
• Seizures
• Infection
• Kidney Damage
• Memory Problems
• Vision Problems
• Sleeplessness

How to Use Zufinib 250 mg Tablet?

​​​​Zufinib Tablet may take with or without food. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.​

How Zufinib 250 mg Tablet Works?

Zufinib Tablet works by inhibiting the activity of the epidermal growth factor receptor (EGFR) protein, which is found on the surface of cells and is involved in the growth and proliferation of cancer cells. When EGFR is activated, it sends signals to the inside of the cell to grow and divide. Zufinib 250 mg binds to the EGFR and prevents it from activating, thereby inhibiting the growth and proliferation of cancer cells.

Safety Advices Zufinib 250 mg Tablet

Driving

Unsafe

Breastfeeding

Unsafe

Liver

Use with Caution

Pregnancy

Unsafe

Kidney

Use with Caution

Alcohol

Unsafe

References

1. Gefitinib Tablets, Natco Pharma (Canada) Inc. Mississauga, Product Leaflet 

2. Iressa 250 Mg Film-coated Tablets, AstraZeneca Ab, Product Monograph 

3. Summary Of Risk Management Plan For Gefitinib 250 Mg Film-coated Tablets, Qilu Pharma Spain S.l. Available Form 

4. Iressa (gefitinib Tablets, AstraZeneca Pharmaceuticals Lp, Uk, Product Monograph 

5. Iressa 250 Mg Film Coated Tablets, AstraZeneca Limited, Product Leaflet 

6. Gefitinib 250 Mg Film-coated Tablet, Available Form